Literature DB >> 29252776

Rapid-Onset Diffuse Skeletal Fluorosis from Inhalant Abuse: A Case Report.

Eric Cohen1, Raymond Y Hsu1, Peter Evangelista1, Roy Aaron1, Lee E Rubin1.   

Abstract

CASE: A thirty-year-old man presented with severely debilitating left hip pain and stiffness. Radiographs demonstrated diffuse osteosclerosis and heterotopic bone formation with near ankylosis of the left hip. The patient underwent successful joint-preserving surgery to restore hip range of motion. After disclosing a history of inhalant abuse, which was confirmed by elevated serum fluoride levels, he was diagnosed with diffuse skeletal fluorosis.
CONCLUSIONS: To the best of our knowledge, we present the first reported case of diffuse skeletal fluorosis caused by inhalant abuse of 1,1-difluoroethane. Skeletal fluorosis is uncommon in the United States but is important to consider in the differential diagnosis when a patient presents with otherwise unexplained joint pain and osteosclerosis.

Entities:  

Year:  2014        PMID: 29252776     DOI: 10.2106/JBJS.CC.N.00085

Source DB:  PubMed          Journal:  JBJS Case Connect        ISSN: 2160-3251


  4 in total

1.  Puffy hands and periosteal hyperostosis from inhalant abuse.

Authors:  Chen Xie; Meika Fang
Journal:  BMJ Case Rep       Date:  2020-01-26

Review 2.  Non-endemic skeletal fluorosis: Causes and associated secondary hyperparathyroidism (case report and literature review).

Authors:  Fiona J Cook; Maighan Seagrove-Guffey; Steven Mumm; Deborah J Veis; William H McAlister; Vinieth N Bijanki; Deborah Wenkert; Michael P Whyte
Journal:  Bone       Date:  2021-01-06       Impact factor: 4.398

3.  Skeletal Fluorosis: A Case of Inhalant Abuse Leading to a Diagnosis of Colon Cancer.

Authors:  Haseeb Mohideen; Dushyant Singh Dahiya; Dustin Parsons; Hafsa Hussain; Rizwan Syed Ahmed
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

4.  1,1-Difluoroethane Detection Time in Blood after Inhalation Abuse Estimated by Monte Carlo PBPK Modeling.

Authors:  Raul Huet; Gunnar Johanson
Journal:  Pharmaceutics       Date:  2020-10-20       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.